Your browser doesn't support javascript.
loading
Privacy-aware multi-institutional time-to-event studies.
Späth, Julian; Matschinske, Julian; Kamanu, Frederick K; Murphy, Sabina A; Zolotareva, Olga; Bakhtiari, Mohammad; Antman, Elliott M; Loscalzo, Joseph; Brauneck, Alissa; Schmalhorst, Louisa; Buchholtz, Gabriele; Baumbach, Jan.
Afiliação
  • Späth J; Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
  • Matschinske J; Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
  • Kamanu FK; TIMI Study Group, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Zolotareva O; Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
  • Bakhtiari M; Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Munich, Germany.
  • Antman EM; Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
  • Loscalzo J; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Brauneck A; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Schmalhorst L; Faculty of Legal Sciences, University of Hamburg, Hamburg, Germany.
  • Buchholtz G; Faculty of Legal Sciences, University of Hamburg, Hamburg, Germany.
  • Baumbach J; Faculty of Legal Sciences, University of Hamburg, Hamburg, Germany.
PLOS Digit Health ; 1(9): e0000101, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36812603
Clinical time-to-event studies are dependent on large sample sizes, often not available at a single institution. However, this is countered by the fact that, particularly in the medical field, individual institutions are often legally unable to share their data, as medical data is subject to strong privacy protection due to its particular sensitivity. But the collection, and especially aggregation into centralized datasets, is also fraught with substantial legal risks and often outright unlawful. Existing solutions using federated learning have already demonstrated considerable potential as an alternative for central data collection. Unfortunately, current approaches are incomplete or not easily applicable in clinical studies owing to the complexity of federated infrastructures. This work presents privacy-aware and federated implementations of the most used time-to-event algorithms (survival curve, cumulative hazard rate, log-rank test, and Cox proportional hazards model) in clinical trials, based on a hybrid approach of federated learning, additive secret sharing, and differential privacy. On several benchmark datasets, we show that all algorithms produce highly similar, or in some cases, even identical results compared to traditional centralized time-to-event algorithms. Furthermore, we were able to reproduce the results of a previous clinical time-to-event study in various federated scenarios. All algorithms are accessible through the intuitive web-app Partea (https://partea.zbh.uni-hamburg.de), offering a graphical user interface for clinicians and non-computational researchers without programming knowledge. Partea removes the high infrastructural hurdles derived from existing federated learning approaches and removes the complexity of execution. Therefore, it is an easy-to-use alternative to central data collection, reducing bureaucratic efforts but also the legal risks associated with the processing of personal data to a minimum.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article